IDH1 and glioblastoma: To characterize GBM infiltrating tumor cells, high‐depth scRNA‐seq data on a cohort containing four GBM patients (diagnosed by pathological results, IDH1‐negative) were collected and analyzed, namely BT S1, BT S2, BT S4, and BT S6.